Skip to main content
. 2019 Feb 14;14(2):e0211918. doi: 10.1371/journal.pone.0211918

Fig 7. Predicting mortality RRs and life-years gained for 2-yearly and 8-yearly screening between 55 and 69 years of age and the cessation of asymptomatic PSA testing compared with current testing patterns.

Fig 7

The shifts in testing policy was introduced 2015 on a population reflecting the Swedish age-structure.